Business
CYCLE: Cyclezyme advances commercialization with new partnerships, improved results, and solid funding
CYCLE: Cyclezyme advances commercialization with new partnerships, improved results, and solid funding
About this update from Cyclezyme Ab
Cyclezyme reported increased revenue and reduced losses in Q1 2025, secured new strategic partnerships, and completed a share issue to fund operations for up to 24 months, positioning itself to benefit from EU recycling mandates and growing market demand.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.